This case and related material will be distributed in class. But, for
this session I would like you to think about India's comparative
advantage in the biotech sector. What is it? Is it sustainable? Is
this model of high tech development appropriate for other developing
countries? What are Biocon's core competencies? Are these sustainable
in the long run? What should the company's next move be? What do you
see as it's major challenges?